Litcius/Paper detail

Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44

Amy L. Cummings, Jaklin Gukasyan, Henry Y. Lu, Tristan Grogan, Gemalene Sunga, Charlene M. Fares, Nicholas J. Hornstein, Jesse M. Zaretsky, James M. Carroll, Benjamin Bachrach, Wisdom O. Akingbemi, Debory Li, Zorawar S. Noor, Aaron Lisberg, Jonathan W. Goldman, David Elashoff, Alex Bui, Antoni Ribas, Steven M. Dubinett, Maura Rossetti, Edward B. Garon

2020Nature Cancer48 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyLung cancerMedicineCancer immunotherapyImmunologyAntigenCancerOncologyImmune systemInternal medicineCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Genomics and Diagnostics
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44 | Litcius